• CDMO specialist signs long-term lease at Unity Campus
• Unity Campus nears full occupancy with latest signing
Cambridge, 13th March 2025: Leading regional property investor and developer Howard Group, is delighted to announce a major new signing at its flagship science and technology hub Unity Campus.
London BioScience Innovation Centre welcomes Laverock Therapeutics to its newly completed fully fitted lab space within the Apex Building, Tribeca London
- Laverock Therapeutics re-locates to LBIC to facilitate future growth, representing a key milestone for the company as it reports significant progress with its platform technologies, product pipeline and commercial offerings
- Fit-out complete, Laverock Therapeutics is the first company to take up occupation within LBIC’s new grow-on lab space at Tribeca London
AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells. This medium now complies with Good Manufacturing Practices, as required for downstream clinical applications.
About us:
The Babraham Research Campus is considered to be the UK’s leading campus to support early-stage bioscience enterprises. World class research and business come together to promote innovation and strengthen links between academia and the commercial world.
There’s still time to register to our in-person event where we will delve into the strategic choices required to successfully launch in Europe through a go-alone strategy.
This event will provide valuable insights from our latest thought leadership report, "Biotech European expansion: Unlocking success through a go-alone strategy".
We will be discussing the choices to consider for:
• A successful launch strategy: Including market access sequencing, pricing strategy, and commercial readiness.
Introducing the BioAI Summit, a BRAND-NEW Bionow event that explores the dynamic relationship between artificial intelligence and life sciences. As AI technologies continue to evolve, their integration into the life sciences sector is paving the way for innovations that were once thought impossible. From accelerating drug discovery to revolutionizing diagnostics and transforming personalised medicine, AI is unlocking new frontiers in biotech and healthcare.
Bionow’s Pharma Manufacturing conference will bring together industry, academic and regulatory experts to share their experiences and expertise through talks, panel discussions, exhibitions and networking to identify challenges and opportunities in the industry.
The event will:
Highlight successful partnerships through invited keynote speakers and via selected case studies
Promote the funding and support available for innovation through a series of short presentations
Include a 1-2-1 partnering activity to encourage interactions between all participating organisations and delegates
Provide an excellent opportunity for informal networking
The Bionow Investment Showcase Webinar is back on the 26th March, and we are pleased to host a webinar for two of our members AMLo Bioscinces and CrystecPharma, who are seeking investment of £10m and £5m respectively as they continue to grow their businesses. Both companies have compelling data, exciting innovative technologies and are supported by strong teams.
Join Bionow & Bruntwood SciTech on Wednesday 19th March for Buisness Pitching followed by Biotech & Beers! From 4pm onwards.